May 8, 2018 / 9:03 PM / 7 months ago

BRIEF-Theravance Biopharma Reports Qtrly Loss Per Share $1.22

May 8 (Reuters) - Theravance Biopharma Inc:

* THERAVANCE BIOPHARMA, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* QTRLY LOSS PER SHARE $1.22

* Q1 EARNINGS PER SHARE VIEW $-1.26 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below